ITERUM THERAPEUTICS US LTD
Profile
Company Names
ITERUM THERAPEUTICS US LTD
Addresses
200 S. WACKER DRIVE, SUITE 2550, CHICAGO, IL 60606
Phone Numbers
312-778-6070
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2015
State Incorporated:
DELAWARE
Total Amount Raised:
$51,588,000.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-01-21
$51,588,000.00
$51,588,000.00
$0.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRENTON
K.
AHRENS
DIRECTOR
LOUISE
BARRETT
DIRECTOR
MARK
CHIN
DIRECTOR
OPTIKIRA, LLC
| ITERUM THERAPEUTICS LTD
| HARPOON THERAPEUTICS, INC.
| AURA BIOSCIENCES, INC.
| VELOSBIO INC.
| IMARA INC.
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| SORRISO PHARMACEUTICALS, INC.
| ENSOMA, INC.
| AVENZOAR PHARMACEUTICALS, INC.
MICHAEL
DUNNE
EXECUTIVE OFFICER, PROMOTER
COREY
N.
FISHMAN
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
JAMES
I.
HEALY
DIRECTOR
CEBIX INCOPRATED
| AMARIN CORP PLC\UK
| SORBENT THERAPEUTICS INC
| CEBIX INC
| HYPERION THERAPEUTICS INC
| ITERUM THERAPEUTICS LTD
| SOFINNOVA VENTURE PARTNERS X, L.P.
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| SEAPORT THERAPEUTICS, INC.
PATRICK
J.
HERON
DIRECTOR
FRAZIER LIFE SCIENCES VIII, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND VIII, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT AFFILIATES VIII, L.P.
| ITERUM THERAPEUTICS LTD
| FRAZIER LIFE SCIENCES IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT AFFILIATES IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND IX PV, L.P.
| IMAGO BIOSCIENCES, INC.
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| MIRUM PHARMACEUTICALS, INC.
| FRAZIER LIFE SCIENCES XI, L.P.
RONALD
M.
HUNT
DIRECTOR
DAVID
KELLY
DIRECTOR
TEXTURA CORP
| WHEELER REAL ESTATE INVESTMENT TRUST, INC.
| CHAKANA RESOURCES CORP
| INNOVASEA SYSTEMS, INC.
| AON PRIVATE CREDIT OPPORTUNITIES FUND, LLC
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| PEPE-S OF BROWARD, LLC
| CONCEPT NEIGHBORHOOD FUND I, LP
| TAPESTRY VC FUND II, LP
| SENSCY INC.
| INDUCTIVEMIND RESEARCH, LLC
| KPS LIFE HOLDCO, LLC
SHAHZAD
MALIK
DIRECTOR
CONATUS PHARMACEUTICALS INC
| PATHWORK DIAGNOSTICS INC
| VERSARTIS, INC.
| ACUTUS MEDICAL, INC.
| IDUN PHARMACEUTICALS INC
| ADVENT LIFE SCIENCES FUND II LP
| AGENUS INC
| NALU MEDICAL, INC.
| AXONICS MODULATION TECHNOLOGIES, INC.
| ITERUM THERAPEUTICS LTD
| ADVENT LIFE SCIENCES FUND III LP
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| ADVENT-HARRINGTON IMPACT FUND LP
| MOXIMED, INC
| ADVENT LIFE SCIENCES GROWTH FUND LP
JUDITH
M.
MATTHEWS
EXECUTIVE OFFICER, PROMOTER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-01-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-01-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-01-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-01-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-01-21
